2.0(top 20%)
impact factor
2.8K(top 10%)
papers
37.0K(top 10%)
citations
76(top 10%)
h-index
2.1(top 20%)
impact factor
4.0K
all documents
39.2K
doc citations
128(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full ReportJournal of Clinical Lipidology2015632
2Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patientsJournal of Clinical Lipidology2011483
3National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2Journal of Clinical Lipidology2015430
4Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patientsJournal of Clinical Lipidology2011406
5National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 – executive summaryJournal of Clinical Lipidology2014396
6Understanding Statin Use in America and Gaps in Patient Education (USAGE): An internet-based survey of 10,138 current and former statin usersJournal of Clinical Lipidology2012395
7An assessment by the Statin Muscle Safety Task Force: 2014 updateJournal of Clinical Lipidology2014391
8Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trialJournal of Clinical Lipidology2015390
9LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study—Implications for LDL managementJournal of Clinical Lipidology2007365
10Obesity, adiposity, and dyslipidemia: A consensus statement from the National Lipid AssociationJournal of Clinical Lipidology2013346
11Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid AssociationJournal of Clinical Lipidology2019315
12Clinical implications of discordance between low-density lipoprotein cholesterol and particle numberJournal of Clinical Lipidology2011311
13Familial Hypercholesterolemias: Prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial HypercholesterolemiaJournal of Clinical Lipidology2011292
14An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia-Full reportJournal of Clinical Lipidology2014289
15Hypolipidemia is associated with the severity of COVID-19Journal of Clinical Lipidology2020278
16High-density lipoproteins: A consensus statement from the National Lipid AssociationJournal of Clinical Lipidology2013276
17“Atherogenic index of plasma” (log10 triglyceride/high-density lipoprotein−cholesterol) predicts high blood pressure, diabetes, and vascular eventsJournal of Clinical Lipidology2010243
18Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialistsJournal of Clinical Lipidology2011235
19Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: A reviewJournal of Clinical Lipidology2012229
20Review of current evidence and clinical recommendations on the effects of low-carbohydrate and very-low-carbohydrate (including ketogenic) diets for the management of body weight and other cardiometabolic risk factors: A scientific statement from the National Lipid Association Nutrition and Lifestyle Task ForceJournal of Clinical Lipidology2019225
21A review of low-density lipoprotein cholesterol, treatment strategies, and its impact on cardiovascular disease morbidity and mortalityJournal of Clinical Lipidology2016219
22Predictors of statin adherence, switching, and discontinuation in the USAGE survey: Understanding the use of statins in America and gaps in patient educationJournal of Clinical Lipidology2013210
23Prevalence of lipid abnormalities in the United States: The National Health and Nutrition Examination Survey 2003–2006Journal of Clinical Lipidology2012206
24Fatty acids in cardiovascular health and disease: A comprehensive updateJournal of Clinical Lipidology2012201
25Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: The EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trialJournal of Clinical Lipidology2014198
26An assessment by the Statin Liver Safety Task Force: 2014 updateJournal of Clinical Lipidology2014189
27Cholesterol crystals piercing the arterial plaque and intima trigger local and systemic inflammationJournal of Clinical Lipidology2010158
28A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: The ECLIPSE (Epanova® compared to Lovaza® in a pharmacokinetic single-dose evaluation) studyJournal of Clinical Lipidology2012156
29Cascade screening based on genetic testing is cost-effective: Evidence for the implementation of models of care for familial hypercholesterolemiaJournal of Clinical Lipidology2014149
30An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemiaJournal of Clinical Lipidology2013147
31The importance of non–HDL cholesterol reporting in lipid managementJournal of Clinical Lipidology2008145
32Pediatric aspects of Familial Hypercholesterolemias: Recommendations from the National Lipid Association Expert Panel on Familial HypercholesterolemiaJournal of Clinical Lipidology2011142
33The risks of statin use in pregnancy: A systematic reviewJournal of Clinical Lipidology2016140
34Severe hypertriglyceridemia is primarily polygenicJournal of Clinical Lipidology2019136
35An assessment by the Statin Intolerance Panel: 2014 updateJournal of Clinical Lipidology2014135
36Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: Design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trialJournal of Clinical Lipidology2014128
37Use of ETC-1002 to treat hypercholesterolemia in patients with statin intoleranceJournal of Clinical Lipidology2015128
38Efficacy and safety of pemafibrate (K-877), a selective peroxisome proliferator-activated receptor α modulator, in patients with dyslipidemia: Results from a 24-week, randomized, double blind, active-controlled, phase 3 trialJournal of Clinical Lipidology2018127
39Altered cholesterol and fatty acid metabolism in Huntington diseaseJournal of Clinical Lipidology2010126
40A clinician's guide to statin drug-drug interactionsJournal of Clinical Lipidology2014124
41Management of Familial Hypercholesterolemias in adult patients: Recommendations from the National Lipid Association Expert Panel on Familial HypercholesterolemiaJournal of Clinical Lipidology2011120
42Treatment with ETC-1002 alone and in combination with ezetimibe lowers LDL cholesterol in hypercholesterolemic patients with or without statin intoleranceJournal of Clinical Lipidology2016119
43Unraveling HDL-Associated Risk: Current Challenges and Future DirectionsJournal of Clinical Lipidology2011115
44NLA Task Force on Statin Safety - 2014 updateJournal of Clinical Lipidology2014114
45High-density lipoprotein subclasses and their relationship to cardiovascular diseaseJournal of Clinical Lipidology2012112
46The effects of adherence and persistence on clinical outcomes in patients treated with statins: A systematic reviewJournal of Clinical Lipidology2010109
47Treatment of adults with Familial Hypercholesterolemia and evidence for treatment: Recommendations from the National Lipid Association Expert Panel on Familial HypercholesterolemiaJournal of Clinical Lipidology2011107
48The risk of cardiovascular events with increased apolipoprotein CIII: A systematic review and meta-analysisJournal of Clinical Lipidology2015106
49Toward an international consensus—Integrating lipoprotein apheresis and new lipid-lowering drugsJournal of Clinical Lipidology2017105
50The National Lipid Association scientific statement on coronary artery calcium scoring to guide preventive strategies for ASCVD risk reductionJournal of Clinical Lipidology2021105